Recruiting
Phase 2

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

Sponsor:

Cellvax Therapeutics Inc

Code:

NCT06636682

Conditions

Prostate Cancer (Adenocarcinoma)

Prostate CA

Prostate Cancers

Prostate Cancer (Post Prostatectomy)

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

FK-PC101

Standard of Care (SOC)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information